Risk minimization measures for medicinal products in Croatia

Apart from the desired therapeutic effect, taking any medication carries the risk of side effects. For some medicinal products, the risk-benefit ratio is positive only with the application of certain additional measures called riskminimization measures (RMM).

RMM aim to optimize the safe and effective use of the medicinal product throughout its life cycle. In addition to routine risk minimization measures for all medicinal products, additional risk minimization measures are carried out for medicines for which there is a specific risk that affects the benefit-risk ratio to the extent that the medication might not remain on the market.

RMM should be a part of optimal drug use in the medical practice, with the aim of using the right medication at the right dose at the right time for the right patient and with the right information and follow-up.

In the Republic of Croatia, the Agency for Medicinal Products and Medical Devices of Croatia (HALMED) participates in coordinating the approval, implementation, and measurement of RMM effectiveness. However, communication and education of healthcare professionals have been recognized as a key to understanding the importance of RMM.

If you would like to learn more about Croatia’s RMM top professionals’ opinion, follow our link in the week to come!

Maša Bulajić; MD, MSc Econ, PhD / Medical Affairs Manager